Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, education, and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and surgical and dental products to veterinary clinics and universities, including dentistry and companion animal orthopedics under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
Frequently asked questions
What sector does Vimian Group AB (publ) (VIMGF) operate in?
Vimian Group AB (publ) belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Vimian Group AB (publ) (VIMGF) current stock price?
As of the latest data, Vimian Group AB (publ) stock price is $2.77, with a previous close of $2.77.
What is Vimian Group AB (publ) (VIMGF) current market capitalization?
Vimian Group AB (publ) market cap is approximately 1.46 billion.
What is Vimian Group AB (publ) (VIMGF) Earnings Per Share (EPS)?
The trailing EPS is $0.07.
What is Vimian Group AB (publ) (VIMGF) Price-to-Earnings (P/E) ratio?
Vimian Group AB (publ) current P/E ratio is 39.57.
What is Vimian Group AB (publ) (VIMGF) EBITDA?
Vimian Group AB (publ) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 31.70 million.
Does Vimian Group AB (publ) (VIMGF) pay dividends?
No. Vimian Group AB (publ) does not pay a dividend.
When is Vimian Group AB (publ) (VIMGF) next earnings report?
Vimian Group AB (publ) is expected to release its next earnings report on September 30, 2026.
What is Vimian Group AB (publ) (VIMGF) beta (volatility) score?
Vimian Group AB (publ) has a beta of 1.128, meaning its volatility is roughly in line with the market.
